Stay on: SunEdison (NYSE:SUNE), Kinross Gold Corporation (NYSE:KGC), Oncolytics Biotech Inc. (NASDAQ:ONCY), Eli Lilly and Company (NYSE:LLY), Crescent Point Energy (NYSE:CPG)


SunEdison Inc. (NYSE:SUNE) and AT&T turn on the 677 kWh solar project located in Lancaster, TX marking another successfully completed project as a part of their ongoing partnership for clean energy solutions. The 677 kWh ground mount project uses 2,000 SunEdison panels and has a 20 year power purchase agreement. On Wednesday shares of SunEdison, Inc. (NYSE:SUNE) closed at $20.29. Company’s EPS growth for next 5 years is recorded as 1.58%.

Kinross Gold Corporation (NYSE:KGC) of Toronto has decided not to proceed with the expansion at its Tasiast gold mine in this African country. The project feasibility study, released in March 2014, proposed that the mill be expanded to 38,000 t/d at a cost of $1.6 billion. Kinross Gold Corporation (NYSE:KGC) in last trading activity decreased -7.72% to close at $2.99. Company weekly performance is -10.48% while its quarterly performance stands at 27.78%. Kinross Gold Corporation (NYSE:KGC) is -45.04% away from its 52 week high.

Oncolytics Biotech Inc. (NASDAQ:ONCY) announced that it has submitted an application to FDA for obtaining orphan drug designation for Reolysin for the treatment of high-grade gliomas (HGG) in pediatric patients. On last trading day Oncolytics Biotech Inc. (NASDAQ:ONCY) increased 1.00% to close at $0.47. Its volatility for the week is 15.14% while volatility for the month is 9.70%. ONCY’s EPS growth for past 5 years was 7.50%. Oncolytics Biotech Inc. (NASDAQ:ONCY) monthly performance is -5.06%.

On February 2, it was reported that, the U.S. Food and Drug Administration (FDA) has approved Glyxambi® (empagliflozin/linagliptin) tablets, from Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (NYSE:LLY), as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes (T2D) when both empagliflozin and linagliptin are appropriate treatments. Eli Lilly and Company (NYSE:LLY) in last trading activity fell -0.78% to close at $69.95. Company weekly performance is -0.38% while its quarterly performance stands at 3.08%. Eli Lilly and Company (NYSE:LLY) is -6.86% away from its 52 week high.

Crescent Point Energy Corp. (NYSE:CPG) confirms that the dividend to be paid on February 17, 2015, in respect of January 2015 production, for shareholders, will be CDN$0.23 per share. On last trading day Crescent Point Energy Corp. (NYSE:CPG) increased 0.04% to close at $25.23. Its volatility for the week is 3.11% while volatility for the month is 4.83%. CPG’s EPS growth for past 5 years was -15.07%. Crescent Point Energy Corp. (NYSE:CPG) monthly performance is 11.64%.


Leave a Reply

Your email address will not be published. Required fields are marked *